Filter your search
Clinical ChemistryX
Clinical chemistry is integral to laboratory testing and is often referred to as a core lab discipline. Reports from Kalorama Information pay special attention to trends in greater healthcare, clinical laboratory investment and automation technology to determine how established in vitro diagnostics (IVD) markets such as clinical chemistry will be affected. This IVD market segment is also routinely analyzed in emerging regions such as China, India, the Middle East, and other Asian countries.
- $1,995.00 – $3,990.00The IVD Market in Vietnam presents current analysis of the Vietnamese IVD industry. Vietnam has demonstrated fast economic growth in recent years. Increases in foreign investment, wages, trade, industrialization and tourism have led to economic growth higher than that of many other economies in Asia. As a result, IVD companies searching for emerging market areas […]August 19, 2015$1,995.00 – $3,995.00IVD in China Market Outlook 2014-2024 With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, […]June 11, 2015$499.00 – $1,000.00The Market for Clinical Chemistry Routine clinical chemistry comprises 30 to 40 tests of substrates, metabolites, electrolytes, blood gases, enzymes and lipids that can be organized into panels for specialty patient investigation and routine patient screening. Common specialty panels include those for renal clearance, liver function, and metabolic status. Clinical chemistries are performed on analyzers […]April 17, 2015$1,995.00 – $3,990.00The Market for IVD in Latin America The Market for IVD in Latin America is an essential resource for IVD companies seeking market information for developing countries with growing economies. Kalorama Information, and VA Consultadora y Asociados of Argentina have published detailed nation by nation market analysis of the IVD markets in LATAM and thier […]January 31, 2015$1,995.00 – $3,990.00The in vitro diagnostics (IVD) market attracts considerable interest. There are hundreds of participating companies, competing in multiple areas of testing. Each IVD segment could be said to function as an industry in and of itself. There are companies who specialize in one area and companies who participate across segments. There are myriad products, from routine blood tests to complicated […]August 13, 2014$1,995.00 – $3,990.00The United States is the world’s largest in vitro diagnostics and nearly half of the global IVD market. While companies seek emerging markets for growth, most healthcare business is generated in the United States and its volume is still a strong advantage of this market. Most recently the U.S. IVD market weathered interrupted lab and […]March 18, 2014$995.00 – $1,990.00Full coverage of the IVD market in Mexico, including important IVD segments.December 16, 2013$1,500.00 – $3,000.00Brazil is the fifth largest country in the world, after Russia, Canada, China and the United States. The size of the country as made it a focus for IVD companies. This report, The IVD Market in Brazil, provides market estimates and forecasts for the main categories of in vitro diagnostics, and forecasts those markets to […]September 13, 2013$1,995.00 – $3,990.00Australia represents a highly competitive IVD market with established international players, a highly developed export-intensive domestic industry, and highly consolidated clinical lab and testing industry. While other developed IVD markets in North America, Europe and Japan are not estimated to be achieving above 3% annual growth, the Australian IVD market has grown at an average […]August 5, 2013$2,500.00 – $5,000.00This report, IVD in China represents Kalorama’s complete analysis on the Chinese IVD market. The report provides an introduction to the healthcare system in China, the results of recent reform efforts, and issues and trends. Regional breakouts of the Chinese system are provided. The report describes the role that out-of-pocket expenditures and private concerns play […]August 5, 2013
